Oppenheimer: The Astria Therapeutics (ATXS.US) rating was maintained, and the target price was adjusted from better than market to better than market, and the target price was adjusted from $29.00 to $25.00.
奥本海默：维持Astria Therapeutics(ATXS.US)评级，由优于大市调整至优于大市评级, 目标价由29.00美元调整至25.00美元。
Oppenheimer: The Astria Therapeutics (ATXS.US) rating was maintained, and the target price was adjusted from better than market to better than market, and the target price was adjusted from $29.00 to $25.00.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.